GLP-1 Drugs for Parkinson’s: Lixisenatide Signal, Exenatide Miss
Parkinson’s disease is the second most common neurodegenerative disorder, affecting around 10 million people worldwide. The mental-health burden is heavy: depression affects 40-50% of patien…
Read article